Lack of impact of YMDD mutants on efficacy or safety of two years therapy with adefovir dipivoxil (ADV) in Chinese HBeAg positive chronic hepatitis B (CHB) patients

被引：0
|
作者：
Mao, Yi-Min
Zeng, Min-De
Zhou, Xia-Qiu
Wang, Hao
Ren, Hong
Niu, Jun-Qi
Dixon, Jonathan S.
Barker, Keith F.
机构：
[1] Renji Hosp, Shanghai, Peoples R China
[2] Ruijin Hosp, Shanghai, Peoples R China
[3] Beijing Peoples Hosp, Beijing, Peoples R China
[4] CMU 2nd Hosp, Chongqing, Peoples R China
[5] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China
[6] GlaxoSmithKline R&D, Brentford, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [21] Predictors of response in patients with HBeAG-positive chronic hepatitis B using adefovir dipivoxil therapy
    Li, J.
    Zhao, H.
    Si, C-W.
    Zhang, Y-X.
    Chen, X-Y.
    Wang, L.
    Tang, X-P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S199 - S200
  • [22] Adefovir dipivoxil 10 mg (ADV) results in consistent efficacy in chronic hepatitis B (CHB) patients with diverse baseline characteristics
    Marcellin, P
    Hadzyannis, S
    Schiff, E
    Peters, M
    Benhamou, Y
    Brosgart, C
    Fry, J
    Wulfsohn, M
    Sullivan, M
    Currie, GM
    JOURNAL OF HEPATOLOGY, 2003, 38 : 153 - 154
  • [23] Histological improvement in HBeAg positive chronic hepatitis B patients treated with adefovir dipivoxil
    Marcellin, P
    Goodman, Z
    Chang, TT
    Lim, SG
    Tong, MR
    Sievert, W
    Shiffman, M
    Jeffers, L
    Wulfsohn, M
    Fallis, R
    Fry, J
    Brosgart, C
    JOURNAL OF HEPATOLOGY, 2002, 36 : 8 - 8
  • [24] Lack of ethnic differences in response to adefovir dipivoxil therapy in HBeAg+ and HBeAg- patients with chronic hepatitis B.
    Lim, SG
    Marcellin, P
    Tassopoulos, N
    Hadziyannis, S
    Chang, TT
    Tong, M
    Sievert, W
    Hu, P
    Currie, G
    James, C
    Choy, GS
    Kearney, B
    Chen, SS
    Brosgart, CL
    HEPATOLOGY, 2003, 38 (04) : 714A - 715A
  • [25] Analysis of HBV polymerase polymorphisms and virological response to adefovir dipivoxil (ADV) in chronic hepatitis B (CHB) patients
    Qi, XP
    Chang, S
    Pang, CF
    Arterburn, S
    Currie, G
    Westland, CE
    Brosgart, CL
    Miller, M
    Xiong, S
    HEPATOLOGY, 2004, 40 (04) : 655A - 655A
  • [26] Predicting HBeAg loss by HBV DNA early kinetics and HBV genotype during treatment of HBeAg plus chronic hepatitis B (CHB) patients with adefovir dipivoxil (ADV)
    Neumann, AU
    Havlin, Y
    Ronen, T
    Tsiang, M
    Wulfsohn, M
    Brosgart, C
    Fry, J
    Westland, C
    Xiong, S
    Gibbs, CS
    JOURNAL OF HEPATOLOGY, 2003, 38 : 26 - 26
  • [27] Increasing serologic, virologic and biochemical response over time to adefovir dipivoxil (ADV) 10 Mg in HBeAg plus chronic hepatitis B (CHB) patients
    Marcellin, P
    Chang, T
    Lim, S
    Sievert, W
    Tong, M
    Arterburm, S
    Xiong, S
    Brosgart, CL
    Currie, G
    GASTROENTEROLOGY, 2005, 128 (04) : A741 - A742
  • [28] Resistance profile of adefovir dipivoxil (ADV) in immunocompetent and immunocompromised chronic hepatitis B patients after 48 weeks of adefovir dipivoxil therapy
    Westland, CE
    Yang, H
    Delaney, WE
    Thibault, V
    Benhamou, Y
    Gibbs, CS
    Miller, MD
    Wulfsohn, M
    Sullivan, M
    Fry, J
    Brosgart, CL
    Xiong, S
    JOURNAL OF HEPATOLOGY, 2003, 38 : 182 - 182
  • [29] DURABILITY OF ADEFOVIR DIPIVOXIL INDUCED HBEAG LOSS FOLLOWING LONG-TERM ADDITIONAL THERAPY IN PATIENTS WITH YMDD MUTANTS OF HEPATITIS B VIRUS
    Kim, Sung Eun
    Chung, Young-Hwa
    Kim, Jeong A.
    Lee, Yoon-Seon
    Lee, Danbi
    Lee, Sae Hwan
    Seo, Dong Dae
    Shin, Jung Woo
    Park, Neung Hwo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Yung Sang
    Suh, Dong Jin
    HEPATOLOGY, 2008, 48 (04) : 704A - 704A
  • [30] Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapy
    Qi, X
    Snow, A
    Thibault, V
    Zhu, Y
    Curtis, M
    Hadziyannis, SJ
    Brosgart, CL
    Currie, G
    Arterburn, S
    Gibbs, CS
    Miller, MD
    Xiong, S
    JOURNAL OF HEPATOLOGY, 2004, 40 : 20 - 21
12345